A randomized, open-label, multicenter, phase 3 study to compare the efficacy and safety of eribulin to treatment of physician’s choice in patients with advanced non-small cell lung cancer
Titel:
A randomized, open-label, multicenter, phase 3 study to compare the efficacy and safety of eribulin to treatment of physician’s choice in patients with advanced non-small cell lung cancer
Auteur:
Katakami, N. Felip, E. Spigel, D.R. Kim, J.-H. Olivo, M. Guo, M. Nokihara, H. Yang, J. C.-H. Iannotti, N. Satouchi, M. Barlesi, F.